Supriya Lifescience gets CRISIL ESG rating of 65 in Strong category

Credit & Debt View source PDF Explain this filing

SUPRIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.4%Reaction day

₹861.00

prior close

₹869.35

announcement price

In-mkt

timing

Nifty Microcap 250market+0.2%+2.2% vs market

Pharmaceuticals peers, median of 168sector-0.3%+2.7% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 2.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.1

15m

+0.4

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.4+0.2+2.2-0.3+2.7

Next day

+1.0+0.9+0.2-0.3+1.4

+1.3-0.8+2.1-1.2+2.5

+2.9-0.1+3.0-1.0+3.9

+1.3-1.7+3.1-2.6+3.9

-1.4-4.3+2.9-4.0+2.6

-5.7-7.5+1.7-6.5+0.8

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Supriya Lifescience has received an ESG rating of CRISIL ESG 65 from CRISIL ESG Ratings & Analytics Limited, placing it in the Strong category. The rating was voluntarily assigned by CRISIL. CRISIL ESG ratings assess performance on environmental, social, and governance parameters, and a score of 65 in the Strong band indicates above-average sustainability practices.

Likely market impact

Positive ESG assessment may appeal to sustainability-focused investors. Limited direct short-term impact on stock price.